Novo Nordisk’s shares fell sharply on Monday after the results from testing the Danish company’s CagriSema drug fell short of investors’ expectations.
Follow topics & set alerts with myFT。一键获取谷歌浏览器下载对此有专业解读
。同城约会对此有专业解读
Share on X (Opens in new window)。关于这个话题，im钱包官方下载提供了深入分析
"I didn't know what was happening," she explained. "The first month I do not remember anything."
Get editor selected deals texted right to your phone!